- Home
- TXG
TXG
10x Genomics Inc.
as 12-18-2024 12:44pm EST
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | PLEASANTON |
| Market Cap: | N/A | IPO Year: | 2019 |
| Target Price: | $25.14 | AVG Volume (30 days): | 1.9M |
| Analyst Decision: | Buy | Number of Analysts: | 16 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.53 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.95 - $57.90 | Next Earning Date: | 10-29-2024 |
| Revenue: | $629,743,000 | Revenue Growth: | 6.56% |
| Revenue Growth (this year): | -2.19% | Revenue Growth (next year): | 6.14% |
Stock Insider Trading Activity of 10x Genomics Inc. (TXG)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Hindson Benjamin J. | TXG | See Remarks | Nov 22 '24 | Sell | $13.69 | 5,807 | $79,485.05 | 339,897 |
Latest 10x Genomics Inc. News
TXG Breaking Stock News: Dive into TXG Ticker-Specific Updates for Smart Investing
Barrons.com
a month ago
If RFK Jr. Cuts Science Funding, These Instrument Makers May Suffer
Insider Monkey
a month ago
10x Genomics, Inc. (TXG): Among the Best Genomics Stocks to Buy Right Now
PR Newswire
a month ago
10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference
Simply Wall St.
2 months ago
Earnings Update: 10x Genomics, Inc. (NASDAQ:TXG) Just Reported And Analysts Are Trimming Their Forecasts
PR Newswire
2 months ago
TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative
MT Newswires
2 months ago
UBS Adjusts Price Target on 10x Genomics to $20 From $25, Maintains Neutral Rating
Thomson Reuters StreetEvents
2 months ago
Q3 2024 10X Genomics Inc Earnings Call
GuruFocus.com
2 months ago
10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...
Compare TXG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TXG 10x Genomics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.